Apple has just recently held its WWDC 2022 event in which it announced new M2 powered MacBooks. But ahead of the schedule, the company had also received clearance for a new feature for its Watch Series 8, which can possibly saves life.
During the WWDC event, the Cupertino based giant had unveiled the new watchOS 9, which is set to bring a number of new features. One of these included a new biomonitoring sensor for AFib burden detection. As per official notes, the brand’s latest Apple Watch will will be able to detects irregular rhythm by monitoring the heartbeat. These irregular rhythms could be indicative of atrial fibrillation (AFib).
For those unaware, an AFib occures when the lower and upper chambers of the heart do not beat in sync. So, the new Apple Watch Series 8, that is expected to launch later this year, could monitor how often a person is in a state of atrial fibrillation over a period of time. Notably, MyHealthyApple reported that the FDA has even given the iPhone maker clearance for the atrial fibrillation tracking feature.
When shipped, the Watch Series 8 might be able to save lives through this feature. AFib affects as many as 9 percent of the population that is above the age of 65 years or older and 2 percent of the population below 65 years of age. However, some of the people affected by AFib never experience any symptoms, and if left untreated, it could lead to risk of heart failure or a stroke.
RELATED:
- Apple announces new 13 inch MacBook Pro powered by the new M2 chipset
- Apple MacBook Air announced with 13.6 inch display, M2 chip, MagSafe charging, and more
- Apple M2 chip with better performance and capabilities announced for Mac devices
